5 FAQs about Class Actions Lawsuits in Ohio
Posted in: Class Actions
Certain health risks and illnesses have been linked to popular weight loss drugs still on the market.
Ozempic and Wegovy, labeled as glucagon-like peptide-1 receptor agonists, are gaining in popularity for weight loss management. These and other GLP-1 medications have come under scrutiny by the Food and Drug Administration (FDA) after the administration reported several complaints through its FDA Adverse Event Reporting System in 2022.
Users have reported lasting issues of gastroparesis, ileus, gallbladder diseases, and more. A lawsuit against drug manufacturers Novo Nordisk and Eli Lilly & Co. was filed in August 2023, with the plaintiff alleging the defendants neglected to inform doctors of possible side effects.
If you or a loved one were diagnosed with gastroparesis, cyclic vomiting syndrome, gallbladder diseases, ileus, or death caused by the above injuries after taking Ozempic or similar GLP-1 medications, you may have a right to financial compensation. Contact Kisling, Nestico & Redick today. We will explain your options for compensation of your medical bills, pain and suffering, lost wages, and more.
Ozempic and other GLP-1 drugs were intended to help people with Type 2 diabetes. The FDA approved the use of Wegovy for chronic weight management in 2021. New concerns have arisen about potential side effects.
Ozempic and Wegovy are semaglutide products. They mimic a naturally produced hormone called “glucagon-like peptide-1” or GLP-1. This hormone causes the pancreas to release insulin and block the liver from releasing sugar.
Semaglutide products help regulate insulin, keeping food in the stomach longer than usual. This sustains the feeling of a full stomach for a longer period. Higher doses interact with the brain to reduce appetite and signal a feeling of fullness.
In March 2022, a warning about gallbladder disease was added to Ozempic’s label. In September 2023, the FDA added a new warning to Ozempic’s label about the risk of ileus.
Research has linked GLP-1 agonists like Ozempic or Wegovy to increased risk of gastroparesis, cyclic vomiting syndrome, gallbladder diseases, and ileus.
Also known as stomach paralysis, gastroparesis is a disorder that slows or stops the movement of food from your stomach to your small intestine. This can happen even when there isn’t a blockage. Symptoms include nausea, vomiting, and feeling full after starting a meal and long after finishing a meal.
GLP-1 users often report experiencing gastroparesis symptoms even after they stop taking medication.
CVS is a disorder that causes repeated episodes of being sick and feeling sick. People with CVS typically vomit repeatedly or feel nausea often. Symptoms include nauseous feelings and extended periods of vomiting; these could be hours or even days of vomiting. Someone with CVS will go through four distinct phases: feeling ill, vomiting, recovering, and then feeling well.
Some Ozempic users have reported gallbladder issues since taking the GLP-1 medication before March 2022. The afflictions vary, but some users reported cases of cancer, gallstones, or inflammation. Your gallbladder is a small organ on the right side of your body. It’s located just below your liver. It holds your body’s bile, a digestive fluid released into your small intestine.
Gallstones are hardened deposits of bile that can form in the gallbladder. They can range in size and number. They can cause a blockage. Symptoms include sudden and intense pain in the upper right or center of your abdomen, pain between your shoulder blades, or nausea and vomiting. Severe cases may require the removal of your gallbladder.
Also called gallbladder inflammation, cholecystitis is a redness or swelling of the gallbladder. It happens after bile becomes trapped in the organ. It can be sudden or long-term. Symptoms include intense pain in your abdomen, nausea, vomiting, fever, jaundice, runny bowel movements, or belly bloating.
A digestive disorder, ileus acts like a blockage, preventing the passage of food, fluids, digestive secretions, and gas through the intestines. There aren’t any actual blockages. Symptoms include abdominal bloating, pain, nausea, vomiting, severe constipation, loss of appetite, and cramps.
Taking these medications has been known to increase the risk of anesthesia-related aspiration, which makes any thoracic surgery more dangerous to complete.
The FDA is monitoring reports that those who took Ozempic experienced an increased risk of thoughts of self-harm and suicidal thoughts. Several users have reported feeling overwhelmed and anxious and an increase in mental health problems since taking the drug.
No two cases are the same, but you deserve the chance to recover financially from your losses.
Your potential recovery from a legal claim or lawsuit connected to a Ozempic-related gastroparesis, CVS, gallbladder diseases, or death may include your past & future medical expenses, lost income, pain & suffering, mental anguish, punitive damages, and wrongful death damages.
You or a loved one may be taking Ozempic and other GLP-1 drugs for an existing medical condition. It’s possible that you may be suffering from adverse side effects even if you stop taking the medication. You could pursue compensation for costs associated with your medical care. That includes your current and future medical expenses the medication has caused.
That may include the expense of monitoring your condition or treating it. Some cases required gastric bypass surgery to achieve some relief.
Some Ozempic users have reported they have missed work because of their condition after taking the GLP-1 medication. Cycles of constant vomiting interfered with their ability to work. If you are experiencing similar issues, you may be eligible for compensation.
Users experiencing adverse side effects of Ozempic and GLP-1 treatments have reported extreme physical pain and mental suffering. If you are experiencing mental anguish after taking Ozempic, you may be able to pursue compensation. Talking to an experienced drug lawsuit attorney at KNR can help you calculate your losses accurately.
In cases of extreme negligence, a court may award a plaintiff punitive damages. These apply in certain cases. These damages are not intended to compensate you but to punish the defendant for their negligent or reckless actions. In this case, drug manufacturers Novo Nordisk and Eli Lilly and Co. have been named in current lawsuits.
In instances when Ozempic’s side effects can be linked to someone’s death, their surviving family may be able to pursue a wrongful death claim. These claims can hold a liable party responsible for their negligent actions that led to a loved one’s death. Talk to our wrongful death attorneys to discuss your case’s legitimacy.
The FDA announces it has started evaluating reports of hair loss, suicidal thoughts, and aspiration under sedation and anesthesia among Ozempic and other GLP-1 users. Several reports were made to the FDA’s Adverse Event Reporting System database.
The judge overseeing a claim against drug manufacturer Novo Nordisk denies the company’s dismissal motion. The judge dismissed express warranty claims against the manufacturer. Plaintiff lawyers filed a motion to consolidate Ozempic cases in Louisiana District Court.
Canadian citizens filed a proposed class action lawsuit in BC Supreme Court alleging Novo Nordisk failed to warn prospective clients adequately about potential complications linked to GLP-1 medications like Ozempic. It is a similar suit to other legal actions.
One of the earliest Ozempic and Mounjaro gastroparesis lawsuits is filed by Jaclyn Bjorklund. Summonses were issued to Novo Nordisk and Eli Lilly and Co. on Aug 3.
The American Society of Health-System Pharmacists advised that Novo Nordisk was running short of Ozempic and Wegovy because of increased demand.
Judges centralized seven lawsuits by Novo Nordisk against generic drug makers for patent infringement into multidistrict litigation in Delaware. The defendants had filed US FDA applications for approval of generic GLP-1 drugs. Lawyers begin accepting Ozempic gallbladder lawsuits after a research letter is published, linking increased risk of gallbladder disease and gallstones to Ozempic use.
If you or a loved one took Ozempic or other GLP-1 medication before you developed gastroparesis or other intestinal afflictions, let KNR assess your damages and eligibility for compensation. With our experience and resources, we can help secure what you’re entitled to without risk or up-front cost.
Contact us today at 1-800-HURT-NOW to schedule a free case evaluation.